Lista de obras - Luana Fianchi - Dominio Público Uruguay

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature

artículo científico publicado en 2011

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

artículo científico publicado en 2017

Acute megakaryoblastic leukemia: experience of GIMEMA trials

artículo científico publicado en 2002

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre.

artículo científico publicado en 2003

Advanced mast cell disease: an Italian Hematological Multicenter experience

artículo científico publicado en 2008

All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients

artículo científico publicado en 2007

Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome

artículo científico publicado en 2017

Aspergillus niger infection in patients with haematological diseases: a report of eight cases

scientific article published on 01 April 2004

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy

scientific article published on 01 March 2010

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

artículo científico publicado en 2011

Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.

artículo científico publicado en 2016

Breakthrough zygomycosis and voriconazole

artículo científico publicado en 2005

Caspofungin for the treatment of candidaemia in patients with haematological malignancies.

artículo científico publicado en 2009

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Clonal evolution in therapy-related neoplasms.

artículo científico publicado en 2017

Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.

artículo científico publicado en 2007

Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis

artículo científico publicado en 2016

Comparison of Real-Time PCR, Conventional PCR, and Galactomannan Antigen Detection by Enzyme-Linked Immunosorbent Assay Using Bronchoalveolar Lavage Fluid Samples from Hematology Patients for Diagnosis of Invasive Pulmonary Aspergillosis.

artículo científico publicado en 2005

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

artículo científico publicado en 2003

Current therapeutic approaches to fungal infections in immunocompromised hematological patients.

scientific article published on 06 January 2010

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.

artículo científico publicado en 2016

Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.

artículo científico publicado en 2009

Epigenetic changes in therapy-related MDS/AML.

artículo científico publicado en 2009

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia.

artículo científico

Factors associated with mortality in bacteremic patients with hematologic malignancies

artículo científico publicado en 2009

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

artículo científico publicado en 2015

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

artículo científico publicado en 2017

Filamentous fungi infection in patients with myelodysplastic syndrome. A report of twelve cases

artículo científico publicado en 2002

Fungal CNS infections in patients with hematologic malignancy.

artículo científico publicado en 2005

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne

artículo científico publicado en 2007

Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.

artículo científico publicado en 2007

Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells.

artículo científico publicado en 2006

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

artículo científico publicado en 2012

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems

artículo científico publicado en 2017

Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome

artículo científico publicado en 2011

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

artículo científico publicado en 2015

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

scientific article published on 08 April 2020

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

artículo científico publicado en 2009

Incidence and susceptibility to therapy-related myeloid neoplasms.

artículo científico publicado en 2009

Incidence of acute myeloid leukemia after breast cancer

artículo científico publicado en 2011

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

artículo científico publicado en 2007

Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

artículo científico publicado en 2016

Invasive fungal infection in patients with myelodysplastic syndrome: a report of twelve cases

artículo científico publicado en 2002

Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

artículo científico publicado en 2016

Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?

artículo científico publicado en 2008

MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.

artículo científico publicado en 2007

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

artículo científico publicado en 2014

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

scientific article published on 04 May 2014

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

artículo científico publicado en 2012

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.

artículo científico publicado en 2006

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

artículo científico publicado en 2012

Outcome of therapy-related myeloid neoplasms treated with azacitidine

artículo científico publicado en 2012

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

artículo científico publicado en 2002

Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium

artículo científico publicado en 2015

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

artículo científico publicado en 2008

Primary plasma cell leukemia followed by testicular plasmacytoma

artículo científico publicado en 2011

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

artículo científico publicado en 2011

Pulmonary aspergillosis in hematologic malignancies: lights and shadows

artículo científico publicado en 2008

Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.

artículo científico publicado en 2005

RNA editing signature during myeloid leukemia cell differentiation.

artículo científico publicado en 2017

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

artículo científico publicado en 2013

Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin

artículo científico publicado en 2014

Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

scientific article published on 28 February 2014

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

artículo científico publicado en 2016

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

artículo científico publicado en 2011

Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.

artículo científico publicado en 2017

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

artículo científico publicado en 2014

Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.

scientific article published on January 2008

Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials

artículo científico publicado en 2004

Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials

artículo científico publicado en 2005

Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura

artículo científico publicado en 2006

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

artículo científico publicado en 2011

Small lymphocytic lymphoma in a patient with Fabry disease.

artículo científico publicado en 2012

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

scientific article published on 01 November 2013

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

scientific article published on 01 September 2005

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

scientific article published on 09 October 2011

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation

artículo científico publicado en 2003

Treatment of Low-Blast Count AML using Hypomethylating Agents

artículo científico publicado en 2017

Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?

artículo científico publicado en 2011

Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.

artículo científico publicado en 2015

Why methylation is not a marker predictive of response to hypomethylating agents.

scientific article published on April 2014

ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.

scientific article published on 18 May 2009

Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).

artículo científico publicado en 2009

Lista de obras de Luana Fianchi

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature

A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.

Acute megakaryoblastic leukemia: experience of GIMEMA trials

Acute myeloid leukemia in elderly patients aged over 75 years: experience of a single centre.

Advanced mast cell disease: an Italian Hematological Multicenter experience

All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients

Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome

Aspergillus niger infection in patients with haematological diseases: a report of eight cases

Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy

Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule

Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.

Breakthrough zygomycosis and voriconazole

Caspofungin for the treatment of candidaemia in patients with haematological malignancies.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

Clonal evolution in therapy-related neoplasms.

Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.

Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis

Comparison of Real-Time PCR, Conventional PCR, and Galactomannan Antigen Detection by Enzyme-Linked Immunosorbent Assay Using Bronchoalveolar Lavage Fluid Samples from Hematology Patients for Diagnosis of Invasive Pulmonary Aspergillosis.

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

Current therapeutic approaches to fungal infections in immunocompromised hematological patients.

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.

Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.

Epigenetic changes in therapy-related MDS/AML.

Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia.

Factors associated with mortality in bacteremic patients with hematologic malignancies

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Filamentous fungi infection in patients with myelodysplastic syndrome. A report of twelve cases

Fungal CNS infections in patients with hematologic malignancy.

Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne

Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.

Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells.

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems

Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

Incidence and susceptibility to therapy-related myeloid neoplasms.

Incidence of acute myeloid leukemia after breast cancer

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

Invasive fungal infection in patients with myelodysplastic syndrome: a report of twelve cases

Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?

MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

Outcome of therapy-related myeloid neoplasms treated with azacitidine

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

Primary plasma cell leukemia followed by testicular plasmacytoma

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

Pulmonary aspergillosis in hematologic malignancies: lights and shadows

Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.

RNA editing signature during myeloid leukemia cell differentiation.

Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin

Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.

Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials

Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials

Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

Small lymphocytic lymphoma in a patient with Fabry disease.

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation